الملخص
Objectives: This study aimed to evaluate the role of a clinical pharmacist intervention in decreasing subsequent clinical and drug-related problems (DRPs) among coronary heart disease (CHD) inpatients with at least one previous DRP. Methods: This pre-experimental study with a pre-post design was carried out from January to April 2017 among inpatients with at least one previous DRP at a general hospital in Tangerang District, Banten, Indonesia. Clinical and DRPs were documented prospectively by a clinical pharmacist, with DRPs classified using Version 6.2 of the DRP classification scheme of the Pharmaceutical Care Network Europe Foundation. The intervention consisted of a discussion of identified DRPs with physicians, patients, pharmaceutical logistics clerks, nurses and nutritionists. Following this, any subsequent clinical and DRPs were re-identified and further interventions were conducted as necessary. Results: A total of 75 inpatients were included in the study. Pre-intervention, there were 443 DRPs and 202 clinical problems. The most frequent DRPs were adverse drug reactions (52.6%), followed by drug effects (41.8%). Most DRPs were of moderate severity and would have resulted in moderate consequences had the pharmacist not intervened. The interventions resulted in a significant reduction in the number of DRPs, type of DRPs and number of clinical problems (P <0.05 each). Patients with complications were 26.047 times more likely to have no reduction or an increased number of clinical problems compared to patients without complications (P <0.05). Conclusion: Clinical pharmacist interventions were found to reduce subsequent DRPs and clinical problems among CHD patients with at least one previous DRP.
بيانات النشر
- المعرّف الرقمي
- 10.18295/squmj.2018.18.01.013
- المجلة
- مجلة جامعة السلطان قابوس الطبية, 18(1), e81-87
- الناشر
- جامعة السلطان قابوس
- وصول مفتوح
- وصول مفتوح ذهبي
- الترخيص
- CC BY-ND 4.0
اقتبس هذه المقالة
APA 7
Sagita, V. A., Bahtiar, A., & Retnosari (2025). Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia. Sultan Qaboos University Medical Journal, 18(1), e81-87. https://doi.org/10.18295/squmj.2018.18.01.013
MLA 9
Sagita, Vina A., et al. "Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia." Sultan Qaboos University Medical Journal, vol. 18, no. 1, 2025, pp. e81-87. https://doi.org/10.18295/squmj.2018.18.01.013.
شيكاغو (المؤلف–التاريخ)
Sagita, Vina A., Anton Bahtiar, and Retnosari. 2025. "Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia." Sultan Qaboos University Medical Journal 18 (1): e81-87. https://doi.org/10.18295/squmj.2018.18.01.013.
هارفارد
Sagita, V. A., Bahtiar, A. and Retnosari (2025) 'Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia', Sultan Qaboos University Medical Journal, 18(1), pp. e81-87. doi:10.18295/squmj.2018.18.01.013.
فانكوفر
Sagita VA, Bahtiar A, Retnosari. Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia. Sultan Qaboos University Medical Journal. 2025;18(1):e81-87. doi:10.18295/squmj.2018.18.01.013
IEEE
V. A. Sagita, A. Bahtiar, and Retnosari, "Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia," Sultan Qaboos University Medical Journal, vol. 18, no. 1, pp. e81-87, 2025, doi: 10.18295/squmj.2018.18.01.013.